obesitas heaviness severe overweight
Conditions
Interventions
Participants will be randomized to either an active screening on HF and its
risk factors (the intervention group) or standard care. The intervention group
will be screened using anamnesis, physical
Sponsors
Cardiologie
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: Age >=45 year, BMI >=30 kg/m2, and written informed consent.
Exclusion criteria
Exclusion criteria: Known cardiac disease (determined by assessment of the available patient files and by asking the patient).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study endpoint is a combined endpoint of left ventricular dysfunction and/or HF admission. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Prevalence at baseline of not yet diagnosed HF as identified by active screening - Prevalence at baseline of undiscovered risk factors for HF (e.g. hypertension, diabetes) as identified by active screening - Risk factors for having HF in subjects with a HF diagnosis at baseline by active screening (e.g. age, sex, BMI, waist circumference, hypertension, diabetes) - Quality of life (EQ-5D-5L questionnaire) at 1 year follow-up in all subjects - Effect of HF treatment on dyspnea (NYHA classification) at 1 year follow-up in screened patients with HF at the time of screening | — |
Countries
Netherlands
Outcome results
None listed